Fig. 4From: SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemiaTranscriptional regulatory effects of SLIT2 promoter methylation on SLIT2-IT1/miR-218 expression in CML. a Relative SLIT2-IT1 expression level in CML patients; b relative SLIT2-IT1 expression between SLIT2 promoter non-hypermethylated and hypermethylated groups; c SLIT2-IT1 expression before and after 5-aza-dC treatment with different dose; d miR-218 expression before and after 5-aza-dC treatment with different dose; e SLIT2 promoter methylation density before 5-aza-dC treatment; f SLIT2 promoter methylation density after 5-aza-dC treatment (4 μM)Back to article page